Ajami M, Sotoudeheian M, Houshiar-Rad A, Esmaili M, Naeini F, Mohammadi Nasrabadi F
Avicenna J Phytomed. 2024; 14(2):189-201.
PMID: 38966631
PMC: 11221767.
DOI: 10.22038/AJP.2023.22920.
Morimoto R, Isegawa Y
Foods. 2023; 12(20).
PMID: 37893759
PMC: 10606521.
DOI: 10.3390/foods12203866.
Klabunde B, Wesener A, Bertrams W, Ringshandl S, Halder L, Vollmeister E
Cell Commun Signal. 2023; 21(1):208.
PMID: 37592354
PMC: 10436572.
DOI: 10.1186/s12964-023-01233-x.
Chen Z, Ye S
Pharm Biol. 2022; 60(1):1063-1076.
PMID: 35634712
PMC: 9154771.
DOI: 10.1080/13880209.2022.2074053.
Kim J, Kim D, Jo J, Byun S
Food Sci Biotechnol. 2022; 31(5):527-538.
PMID: 35437360
PMC: 9007579.
DOI: 10.1007/s10068-022-01073-4.
Modulating Neurological Complications of Emerging Infectious Diseases: Mechanistic Approaches to Candidate Phytochemicals.
Fakhri S, Pour P, Piri S, Farzaei M, Echeverria J
Front Pharmacol. 2021; 12:742146.
PMID: 34764869
PMC: 8576094.
DOI: 10.3389/fphar.2021.742146.
Bioactivity, bioavailability, and gut microbiota transformations of dietary phenolic compounds: implications for COVID-19.
Augusti P, Conterato G, Denardin C, Prazeres I, Serra A, Bronze M
J Nutr Biochem. 2021; 97:108787.
PMID: 34089819
PMC: 8169570.
DOI: 10.1016/j.jnutbio.2021.108787.
Effectiveness of supplementation with quercetin-type flavonols for treatment of viral lower respiratory tract infections: Systematic review and meta-analysis of preclinical studies.
Brito J, Lima W, Cordeiro L, da Cruz Nizer W
Phytother Res. 2021; 35(9):4930-4942.
PMID: 33864310
PMC: 8250479.
DOI: 10.1002/ptr.7122.
Kidney diseases and COVID-19 infection: causes and effect, supportive therapeutics and nutritional perspectives.
Askari H, Sanadgol N, Azarnezhad A, Tajbakhsh A, Rafiei H, Safarpour A
Heliyon. 2021; 7(1):e06008.
PMID: 33495739
PMC: 7817396.
DOI: 10.1016/j.heliyon.2021.e06008.
Quercetin as a Natural Therapeutic Candidate for the Treatment of Influenza Virus.
Mehrbod P, Hudy D, Shyntum D, Markowski J, Los M, Ghavami S
Biomolecules. 2020; 11(1).
PMID: 33374214
PMC: 7824064.
DOI: 10.3390/biom11010010.
Phytogenic Products and Phytochemicals as a Candidate Strategy to Improve Tolerance to Coronavirus.
Attia Y, Alagawany M, Farag M, Alkhatib F, Khafaga A, Abdel-Moneim A
Front Vet Sci. 2020; 7:573159.
PMID: 33195565
PMC: 7606864.
DOI: 10.3389/fvets.2020.573159.
Research Progress of the Antiviral Bioactivities of Natural Flavonoids.
Wang L, Song J, Liu A, Xiao B, Li S, Wen Z
Nat Prod Bioprospect. 2020; 10(5):271-283.
PMID: 32948973
PMC: 7500501.
DOI: 10.1007/s13659-020-00257-x.
Differential Redox State Contributes to Sex Disparities in the Response to Influenza Virus Infection in Male and Female Mice.
Celestino I, Checconi P, Amatore D, De Angelis M, Coluccio P, Dattilo R
Front Immunol. 2018; 9:1747.
PMID: 30105026
PMC: 6077261.
DOI: 10.3389/fimmu.2018.01747.
Progress of small molecular inhibitors in the development of anti-influenza virus agents.
Wu X, Wu X, Sun Q, Zhang C, Yang S, Li L
Theranostics. 2017; 7(4):826-845.
PMID: 28382157
PMC: 5381247.
DOI: 10.7150/thno.17071.
An extract from Taxodium distichum targets hemagglutinin- and neuraminidase-related activities of influenza virus in vitro.
Hsieh C, Chen Y, Lin C, Ho J, Huang C, Chiu C
Sci Rep. 2016; 6:36015.
PMID: 27796330
PMC: 5086851.
DOI: 10.1038/srep36015.
Multi-Omics Studies towards Novel Modulators of Influenza A Virus-Host Interaction.
Soderholm S, Fu Y, Gaelings L, Belanov S, Yetukuri L, Berlinkov M
Viruses. 2016; 8(10).
PMID: 27690086
PMC: 5086605.
DOI: 10.3390/v8100269.
Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice.
Galabov A, Mileva M, Simeonova L, Gegova G
Antivir Chem Chemother. 2016; 24(3-4):83-91.
PMID: 27341844
PMC: 5890525.
DOI: 10.1177/2040206616656263.
Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.
Gasparini R, Amicizia D, Lai P, Bragazzi N, Panatto D
J Prev Med Hyg. 2015; 55(4):109-29.
PMID: 26137785
PMC: 4718316.
Respiratory Viral Infections and Subversion of Cellular Antioxidant Defenses.
Komaravelli N, Casola A
J Pharmacogenomics Pharmacoproteomics. 2015; 5(4).
PMID: 25584194
PMC: 4288774.
DOI: 10.4172/2153-0645.1000141.
Oxidative stress and free radicals in COPD--implications and relevance for treatment.
Domej W, Oettl K, Renner W
Int J Chron Obstruct Pulmon Dis. 2014; 9:1207-24.
PMID: 25378921
PMC: 4207545.
DOI: 10.2147/COPD.S51226.